Cardinal Health, Inc. $CAH Stock Bought by Ritholtz Wealth Management

Ritholtz Wealth Management grew its holdings in Cardinal Health, Inc. (NYSE:CAH) by 13.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 35,614 shares of the company’s stock after purchasing an additional 4,287 shares during the period. Ritholtz Wealth Management’s holdings in Cardinal Health were worth $7,924,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in CAH. Bank of New York Mellon Corp acquired a new stake in shares of Cardinal Health in the second quarter valued at about $308,640,000. First Nebraska Trust Co bought a new stake in Cardinal Health during the second quarter worth about $20,050,000. Castlekeep Investment Advisors LLC acquired a new position in Cardinal Health during the second quarter valued at approximately $1,177,000. Saudi Central Bank boosted its position in Cardinal Health by 87.8% during the second quarter. Saudi Central Bank now owns 16,472 shares of the company’s stock valued at $3,913,000 after purchasing an additional 7,702 shares during the last quarter. Finally, Nilsine Partners LLC grew its stake in Cardinal Health by 437.7% in the second quarter. Nilsine Partners LLC now owns 6,049 shares of the company’s stock valued at $1,437,000 after purchasing an additional 4,924 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.

Analyst Ratings Changes

Several research analysts have weighed in on the company. Mizuho set a $290.00 price target on Cardinal Health in a research report on Thursday, November 5th. Leerink Partners set a $292.00 price objective on Cardinal Health in a report on Tuesday, August 11th. JPMorgan Chase & Co. raised their target price on shares of Cardinal Health from $260.00 to $286.00 and gave the company a “neutral” rating in a research note on Tuesday. Citigroup boosted their target price on shares of Cardinal Health from $265.00 to $280.00 and gave the stock a “buy” rating in a report on Wednesday, August 12th. Finally, Robert W. Baird upped their price target on shares of Cardinal Health from $251.00 to $274.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 12th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $275.62.

Top Cardinal Health Stories

Investors following CAH have been watching these stories:

• Positive Sentiment: Cardinal Health approved a quarterly dividend of $0.5158 per share, payable January 15, 2027, to shareholders of record on January 4. The declaration provides continued income for shareholders, though the article does not offer a new outlook on dividend growth. Cardinal Health Board of Directors Approves Quarterly Dividend
• Positive Sentiment: Zacks highlighted CAH’s momentum and growth characteristics, while a separate screen included the company among stocks with strong interest coverage and financial resilience. These are supportive assessments, not new company announcements. Zacks Cardinal Health Momentum Stock Article
• Neutral Sentiment: Other coverage asks whether the dividend is safe and whether the company can repeat its past performance; the headlines alone do not provide new financial results or a clear change in outlook. Is Cardinal Health’s Dividend Safe? Can Cardinal Health Stock Repeat Its Last Five Years?

Insider Buying and Selling at Cardinal Health

In related news, insider Michelle Greene sold 11,650 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $235.72, for a total transaction of $2,746,138.00. Following the transaction, the insider directly owned 10,330 shares of the company’s stock, valued at approximately $2,434,987.60. The trade was a 53.00% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Stephen Mason sold 35,000 shares of the stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $236.40, for a total value of $8,274,000.00. Following the completion of the sale, the chief executive officer owned 18,061 shares in the company, valued at approximately $4,269,620.40. This trade represents a 65.96% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 210,271 shares of company stock worth $49,626,657 in the last three months. 0.12% of the stock is owned by insiders.

Cardinal Health Stock Performance

Shares of NYSE:CAH opened at $277.63 on Thursday. Cardinal Health, Inc. has a 52-week low of $180.45 and a 52-week high of $286.29. The company has a market capitalization of $64.17 billion, a P/E ratio of 35.92, a price-to-earnings-growth ratio of 2.12 and a beta of 0.53. The company has a 50-day simple moving average of $242.85 and a 200 day simple moving average of $224.57.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, November 5th. The company reported $3.26 earnings per share for the quarter, topping analysts’ consensus estimates of $2.94 by $0.32. The firm had revenue of $67.51 billion for the quarter, compared to the consensus estimate of $66.67 billion. Cardinal Health had a negative return on equity of 102.72% and a net margin of 0.71%. The business’s revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.55 earnings per share. As a group, equities analysts forecast that Cardinal Health, Inc. will post 12.96 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 15th. Stockholders of record on Monday, January 4th will be paid a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Monday, January 4th. Cardinal Health’s payout ratio is currently 26.65%.

Cardinal Health Company Profile

Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.